Global Cholesterol Test Kits Market Overview
Cholesterol Test Kits Market is expected to reach USD 7.3 Billion by 2034, having grown to USD 14.6 Billion in 2024 at a compound annual growth rate (CAGR) of 7.9%.
Cholesterol is a wax-like, fatty substance found in our body. The liver prepares and quantifies the cholesterol needed by the body consistent with the need. The additional cholesterol produce is termed as bad cholesterol. If the cholesterol level exceeds the specified quantity within the body, it can build abreast of walls of arteries termed as plaque and eventually harden. This process is named atherosclerosis. Atherosclerosis narrows the arteries, making it harder for blood to travel through the vessels, resulting in cardiovascular diseases. Unfortunately, high cholesterol doesn't cause symptoms. In later stages of atherosclerosis, it's going to cause a private to suffer angina -- severe pain from lack of blood flow to the guts. If an artery gets totally blocked, it may result during a heart failure.
According to FDA, the total cholesterol level should be 200mg/dL or less, according to recommendations in the National Cholesterol Education Program (NCEP) Third Adult Treatment Panel (ATP III). According to the NCEP, the recommended LDL values should be less than 100 mg/dL, HDL values greater or equal to 40 mg/dL, and triglyceride values less than 150 mg/dL.
Global Cholesterol Test Kits Market Drivers & Restraints
Rising prevalence of cardiovascular diseases and obesity is expected to significantly fuel the demand for cholesterol testing products and services. Population above 18 years of age is recommended to undergo blood cholesterol testing every five years. Patients with a history of heart attacks require cholesterol screening on a regular basis to monitor the effectiveness of their treatment. As recommended by the National Heart, Lung, and Blood Institute, cholesterol testing should be done at least once between the age of 9 to 11 and 17 to 21. According to the Centers for Disease Control and Prevention (CDC), adults between the ages of 40 to 59 have the highest level of total cholesterol, which is 17.1%. This is mainly attributed to the sedentary lifestyle leading to the development of numerous diseases, such as obesity, diabetes, and heart diseases. Increased awareness regarding routine testing and management of healthy cholesterol levels is anticipated to drive the demand for diagnostic products and services.
Increasing geriatric population
The aging population is increasing worldwide, with the most rapid growth in low- and middle-income countries. About 185 million people were above 60 years of age in 2015 (15.7% of the population), and this number is expected to touch 487 million by 2053 (36.5% of the population). Moreover, around 857,040 of the older population is likely to reside in Asia by 2050. In 2016, approximately 18% and 2.4% of the total population in the UK were aged over 65 years and 85 years, respectively. However, the emergence of noninvasive cholesterol testing methods might be hampering the market.
Global Cholesterol Test Kits Market Segmentations & Regional Insights
Cholesterol test kits market is segmented based on product type, test, end-user and region.
On the basis of product type, the global cholesterol test kits market is segmented into test strip kits, and analyzer kits. Based on test, the target market is segmented into total cholesterol test, HDL cholesterol test, LDL cholesterol test, triglycerides/VLDL cholesterol test, and others. Based on end-user, the target market segmented into clinics, hospitals, ambulatory surgical centers, home care settings, and diagnostic centers.
On region the Global Cholesterol Test Kits Market is segmented into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. North America held the largest revenue share in 2018 due to the rise in prevalence of heart diseases and obesity in the U.S. According to the United Health Foundation's annual report, in the U.S., the obesity rate increased from 29.9% in 2017 to 31.3% in 2018. In addition, the growing preference for preventive healthcare is also projected to drive regional growth. Growing awareness and efforts from the government and various organizations are expected to fuel the market growth. The Asia Pacific is expected to witness lucrative growth over the forecast period owing to the rise in population in this region. Asia accounts for around 60% of the world’s population. Increasing cardiovascular diseases is another factor driving the regional market growth. The rise in the number of new diagnostic centres and pathological laboratories is also expected to foster the regional demand for cholesterol testing products and services.
Cholesterol Test Kits Market Report Scope:
Attribute |
Details |
Base year for estimation |
2023 |
Forecast period |
2024 – 2034 |
Market representation |
Revenue in USD Billion & CAGR from 2024 – 2034 |
Market Segmentation |
By Product Type- Test Strip Kits and Analyzer Kits By Test- Total Cholesterol Test, HDL Cholesterol Test, LDL Cholesterol Test, Triglycerides/VLDL Cholesterol Test, and Others By End-user- Clinics, Hospitals, Ambulatory Surgical Centers, Home Care Settings, and Diagnostic Centers |
Delivery Mode Regional scope |
North America - U.S., Canada Europe - UK, Germany, Spain, France, Italy, Russia, Rest of Europe Asia Pacific - Japan, India, China, South Korea, Australia, Rest of Asia-Pacific Latin America - Brazil, Mexico, Argentina, Rest of Latin America Middle East & Africa - South Africa, Saudi Arabia, UAE, Rest of Middle East & Africa |
Report coverage |
Revenue forecast, company share, competitive landscape, growth factors, and trends |
Segments Covered in the Report:
This report forecasts revenue growth at global, regional, and country levels and provides an analysis of the latest industry trends and opportunities in each of the sub-segments from 2024 to 2034. For the purpose of this study, has segmented the Global cholesterol test kits market report based on product type, test, end-user, and region.
Cholesterol Test Kits Market, By Product type:
- Test Strip Kits
- Analyzer Kits
Cholesterol Test Kits Market, By Test:
- Total Cholesterol Test
- HDL Cholesterol Test
- LDL Cholesterol Test
- Triglycerides/VLDL Cholesterol Test
- Others
Cholesterol Test Kits Market, By End-user:
- Clinics
- Hospitals
- Ambulatory Surgical Centers
- Home Care Settings
- Diagnostic Centers
Cholesterol Test Kits Market, By Region:
- North America
- Middle East & Africa
- GCC
- Israel
- South Africa
- Rest of Middle East & Africa
- Latin America
- Brazil
- Mexico
- Rest of Latin America
- Asia Pacific
- China
- India
- Japan
- South Korea
- Rest of Asia Pacific
- Europe
- Germany
- UK
- France
- Russia
- Italy
- Rest of Europe
- U.S.
- Canada
- Middle East & Africa
Global Cholesterol Test Kits Market Competitive Landscape & Key Players
The key players operating in the cholesterol test kits market includes Quest Diagnostics Incorporated, Cell Biolabs, Inc., Clinical Reference Laboratory, Inc., Laboratory Corporation of America Holdings, Randox Laboratories Ltd., Thermo Fisher Scientific, PTS DIAGNOSTICS, Alere Inc., Hoffmann-La Roche AG, and Eurofins Scientific. The market is especially characterized by collaborations and partnerships between the businesses and acquisitions of smaller players as a part of strategic expansion as well as launching their new product specimen. For instance, in 2017, Quest Diagnostics introduced a novel, nonfasting cholesterol testing with improved LDL calculation method for improved accuracy and patient comfort.
Global Cholesterol Test Kits Market Company Profile
- Quest Diagnostics Incorporated
- Cell Biolabs, Inc.
- Clinical Reference Laboratory, Inc.
- Laboratory Corporation of America Holdings
- Randox Laboratories Ltd.
- Thermo Fisher Scientific
- PTS DIAGNOSTICS
- Alere, Inc.
- Hoffmann-La Roche AG
- Eurofins Scientific
Global Cholesterol Test Kits Market Highlights
FAQs
The Cholesterol Test Kits Market accounted for 413.5 Million in 2020 and is estimated to be US$ 513.3 Million by 2029 and is anticipated to register a CAGR of 2.3%.
The market report has been segmented on the basis of product type, test, end-user and region.
Growing prevalence of cardiovascular diseases, increasing awareness about preventive healthcare, and technological advancements in diagnostic devices drive the Cholesterol Test Kits market.
Limited accuracy of some kits, concerns about user compliance, and competition from alternative diagnostic methods pose restraints in the Cholesterol Test Kits market.
North America, Europe, Asia-Pacific, Latin America, and the Middle East & Africa are considered regions in the Cholesterol Test Kits market. North America is expected to dominate, driven by a high burden of cardiovascular diseases, a well-established healthcare infrastructure, and the presence of key market players in the region.
The prominent player operating in the global cholesterol test kits market includes Quest Diagnostics Incorporated, Cell Biolabs, Inc., Clinical Reference Laboratory, Inc., Laboratory Corporation of America Holdings, Randox Laboratories Ltd., Thermo Fisher Scientific, PTS DIAGNOSTICS, Alere Inc., Hoffmann-La Roche AG, and Eurofins Scientific.